Baxter PE Ratio 2006-2019 | BAX

Current and historical p/e ratio for Baxter (BAX) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Baxter PE ratio as of October 18, 2019 is 27.20.
Baxter PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-10-18 87.99 29.63
2019-06-30 81.90 $2.97 27.58
2019-03-31 81.31 $2.94 27.66
2018-12-31 65.82 $2.99 22.01
2018-09-30 76.88 $2.21 34.79
2018-06-30 73.45 $1.66 44.25
2018-03-31 64.52 $1.51 42.73
2017-12-31 63.97 $1.29 49.59
2017-09-30 61.95 $1.86 33.31
2017-06-30 59.61 $1.65 36.13
2017-03-31 50.93 $3.36 15.16
2016-12-31 43.43 $8.99 4.83
2016-09-30 46.49 $8.92 5.21
2016-06-30 44.04 $8.68 5.07
2016-03-31 39.89 $7.09 5.63
2015-12-31 36.94 $1.75 21.11
2015-09-30 31.71 $3.12 10.16
2015-06-30 36.38 $3.98 9.14
2015-03-31 35.37 $4.33 8.17
2014-12-31 37.55 $4.56 8.23
2014-09-30 36.51 $3.41 10.71
2014-06-30 36.53 $3.54 10.32
2014-03-31 36.91 $3.66 10.09
2013-12-31 34.64 $3.65 9.49
2013-09-30 32.48 $3.95 8.22
2013-06-30 34.01 $4.02 8.46
2013-03-31 35.41 $4.14 8.55
2012-12-31 32.29 $4.18 7.72
2012-09-30 28.99 $4.11 7.05
2012-06-30 25.37 $4.06 6.25
2012-03-31 28.35 $3.94 7.19
2011-12-31 23.33 $3.88 6.01
2011-09-30 26.29 $3.78 6.96
2011-06-30 27.80 $3.78 7.35
2011-03-31 24.91 $3.61 6.90
2010-12-31 23.31 $3.49 6.68
2010-09-30 21.84 $3.71 5.89
2010-06-30 18.48 $3.57 5.18
2010-03-31 26.27 $3.63 7.24
2009-12-31 26.36 $3.60 7.32
2009-09-30 25.48 $3.57 7.14
2009-06-30 23.56 $3.44 6.85
2009-03-31 22.66 $3.33 6.80
2008-12-31 23.59 $3.17 7.44
2008-09-30 28.74 $3.00 9.58
2008-06-30 27.91 $2.87 9.73
2008-03-31 25.15 $2.67 9.42
2007-12-31 25.16 $2.61 9.64
2007-09-30 24.30 $2.53 9.61
2007-06-30 24.25 $2.49 9.74
2007-03-31 22.61 $2.31 9.79
2006-12-31 19.84 $2.13 9.32
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $44.852B $11.127B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.598B 26.57
Medtronic (MDT) Ireland $145.585B 20.43
Stryker (SYK) United States $80.642B 27.89
Boston Scientific (BSX) United States $53.170B 25.79
EssilorLuxottica Societe Anonyme (ESLOY) France $32.725B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.438B 18.20
Coloplast (CLPBY) Denmark $25.747B 41.10
Lonza Group Ag (LZAGY) Switzerland $25.481B 0.00
Terumo (TRUMY) Japan $24.495B 30.57
Smith & Nephew SNATS (SNN) United Kingdom $20.928B 0.00
ResMed (RMD) United States $18.924B 36.06
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.234B 54.86
Insulet (PODD) United States $9.431B 558.86
Perrigo (PRGO) Ireland $7.400B 13.63
Canopy Growth (CGC) Canada $7.222B 0.00
Hill-Rom Holdings (HRC) United States $6.830B 20.36
Haemonetics (HAE) United States $6.455B 48.71
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $4.002B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.680B 0.00
Neogen (NEOG) United States $3.490B 58.40
NuVasive (NUVA) United States $3.398B 27.09
ICU Medical (ICUI) United States $3.237B 21.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.634B 0.00
Quidel (QDEL) United States $2.510B 24.93
Agios Pharmaceuticals (AGIO) United States $1.982B 0.00
National Vision Holdings (EYE) United States $1.877B 40.51
Cardiovascular Systems (CSII) United States $1.670B 0.00
Aphria (APHA) $1.242B 0.00
VAREX IMAGING (VREX) United States $1.124B 25.90
AtriCure (ATRC) United States $1.059B 0.00
Phibro Animal Health (PAHC) United States $0.867B 14.10
Eagle Pharmaceuticals (EGRX) United States $0.854B 21.78
NanoString Technologies (NSTG) United States $0.787B 0.00
Omeros (OMER) United States $0.759B 0.00
Lantheus Holdings (LNTH) United States $0.734B 19.29
PetIQ (PETQ) United States $0.725B 17.13
LeMaitre Vascular (LMAT) United States $0.689B 40.82
Cerus (CERS) United States $0.624B 0.00
Surmodics (SRDX) United States $0.621B 118.00
MacroGenics (MGNX) United States $0.560B 0.00
Quanterix (QTRX) United States $0.548B 0.00
TG Therapeutics (TGTX) United States $0.530B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.23
Owens & Minor (OMI) United States $0.459B 13.76
Meridian Bioscience (VIVO) United States $0.427B 13.32
Utah Medical Products (UTMD) United States $0.354B 25.91
Zynex (ZYXI) United States $0.346B 36.76
BioLife Solutions (BLFS) United States $0.339B 104.19
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.327B 0.00
Bovie Medical (APYX) United States $0.234B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Vapotherm (VAPO) United States $0.177B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.147B 0.00
Female Health (VERU) United States $0.138B 0.00
Fonar (FONR) United States $0.133B 9.32
InfuSystems Holdings (INFU) United States $0.127B 0.00
Liberty Health Sciences (LHSIF) Canada $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.088B 0.00
Nephros (NEPH) United States $0.087B 0.00
United-Guardian (UG) United States $0.084B 19.82
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Surface Oncology (SURF) United States $0.039B 0.00
Senestech (SNES) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.020B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00